MedPath

吉林省神经精神病医院制药厂

Ownership
-
Established
2005-05-16
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

9

NMPA:9

Drug Approvals

Phenobarbital and Sodium Bromide Tablets

Product Name
复方苯巴比妥溴化钠片
Approval Number
国药准字H22025507
Approval Date
Jan 19, 2020
NMPA

Alprazolam Tablets

Product Name
阿普唑仑片
Approval Number
国药准字H22026350
Approval Date
Jan 19, 2020
NMPA

Troxerutin Tablets

Product Name
曲克芦丁片
Approval Number
国药准字H22026371
Approval Date
Jan 19, 2020
NMPA

Vitamin B1 Tablets

Product Name
维生素B1片
Approval Number
国药准字H22026354
Approval Date
Jan 19, 2020
NMPA

oxytetracycline Tabets

Product Name
土霉素片
Approval Number
国药准字H22026353
Approval Date
Jan 19, 2020
NMPA

Chlorpromazine Hydrochloride Tablets

Product Name
盐酸氯丙嗪片
Approval Number
国药准字H22026356
Approval Date
Jan 19, 2020
NMPA

Perphenazine Tablets

Product Name
奋乃静片
Approval Number
国药准字H22026351
Approval Date
Jan 19, 2020
NMPA

Clozapine Tablets

Product Name
氯氮平片
Approval Number
国药准字H22026352
Approval Date
Jan 19, 2020
NMPA

Vitamin C Tablets

Product Name
维生素C片
Approval Number
国药准字H22026355
Approval Date
Jan 19, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.